The Case for Health Equity Platforms in Rare Disease Research

Published: 05 Jun 2026

A health equity platform in rare disease is more than software — it is connective tissue between pharma, advocacy, clinicians, and underserved patient communities.

Unlike disease databases or patient story sites, health equity infrastructure supports ongoing collaboration: trial design, recruitment, community engagement, and measurable inclusion outcomes.

What health equity infrastructure enables

• Trusted advocacy partnerships before protocols are finalized
• Cross-sector alignment on inclusive enrollment strategies
• Shared frameworks for community engagement and compliance

Explore our platform · Join the network · Our health equity mission